Startseite A positive urine pregnancy test (UPT) with adnexal mass; ectopic pregnancy is not the ultimate diagnosis
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

A positive urine pregnancy test (UPT) with adnexal mass; ectopic pregnancy is not the ultimate diagnosis

  • Mohd Faizal Ahmad ORCID logo , Muhammad Azrai Abu ORCID logo , Kah Teik Chew ORCID logo , Kun Leng Sheng und Mohd Asyraf Zakaria
Veröffentlicht/Copyright: 20. März 2018
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

A positive urine pregnancy test (UPT) with adnexal mass in ectopic pregnancy is not the ultimate diagnosis. The incidence of ectopic pregnancy is about 27 per 1000 pregnancies [1]. On average, about 6–16% will present to an emergency department with first-trimester bleeding and abdominal pain [2]. On presenting with these symptoms with the simultaneous presence of an adnexal mass and an empty uterus, a UPT is of paramount importance to determine whether the symptoms are pregnancy related or not. When the UPT is positive, an ectopic pregnancy is not the only diagnosis as the rare entity of non-gestational ovarian choriocarcinoma (NGOC) should be considered. Here we present two case reports of NGOC, which were initially diagnosed as ectopic pregnancy. The first case is a 16-year-old girl, with vaginal bleeding and an adnexal mass due to an ovarian choriocarcinoma, She underwent unilateral oophorectomy and received multiple courses of chemotherapy. She is disease free without evidence of recurrence or metastasis after 12 months of follow-up. The second patient is also 16 years old and presented with an acute abdomen. She was diagnosed as a ruptured luteal cyst and underwent partial oophorectomy. When the pathologist diagnosed a choriocarcinoma she received multiple courses of chemotherapy, but thereafter an advanced disease was diagnosed with evidence of distant metastasis.

Author Statement

  1. Research funding: Authors state no funding involved.

  2. Conflict of interest: Authors state no conflict of interest.

  3. Informed consent: Informed consent has been obtained from all individuals.

  4. Ethical approval: The conducted research is not related to either human or animals use.

References

[1] Van Den Eeden SK, Shan J, Bruce C, Glasser M. Ectopic pregnancy rate and treatment utilization in a large managed care organization. Obstet Gynecol. 2005;105(Pt 1):1052–7.10.1097/01.AOG.0000158860.26939.2dSuche in Google Scholar PubMed

[2] Murray HB, Bardell H, Tulandi T. Diagnosis and treatment of ectopic pregnancy. Can Med Assoc J. 2005;173:905–12.10.1503/cmaj.050222Suche in Google Scholar PubMed PubMed Central

[3] Mohd Faizal A, Dianie DJ, Suguna S, Soon R, Moharzudi M. A pure nongestational choriocarcinoma of ovary: sharing experience in sabah. J Surg Academia. 2015;5:51–3.Suche in Google Scholar

[4] Choi YJ, Chun KY, Kim YW, Ro DY. Pure nongestational choriocarcinoma of the ovary: a case report. World J Surg Oncol. 2013;11:7.10.1186/1477-7819-11-7Suche in Google Scholar PubMed PubMed Central

[5] Lv L, Yang K, Wu H, Lou J, Peng Z. Pure choriocarcinoma of the ovary: a case report. J Gynecol Oncol. 2011;22:135–9.10.3802/jgo.2011.22.2.135Suche in Google Scholar PubMed PubMed Central

Received: 2018-1-9
Accepted: 2018-2-16
Published Online: 2018-3-20

©2018 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 23.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2018-0004/html?lang=de
Button zum nach oben scrollen